Trial intelligence / Profile preview

Fascia Iliaca Compartment Block in Hip Fracture Patients

NCT04837924Phase 4Completed

Sponsor
General Hospital Sveti Duh
Start
Apr 2021
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levobupivacaine in hip fracture, sponsored by General Hospital Sveti Duh. Started Apr 2021; status: completed.

02

Drugs

levobupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on NCT04837924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04837924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call